Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen

Annals of Oncology

Volumn 9, Issue 11, 1998, Pages 1251-1253

  Andre T ^a,b   Louvet, C ^b   Raymond, E ^b   Tournigand, C ^b   De Gramont, A ^b  

^a HÔPITAL TENON   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

5 fluorouracil; Advanced colorectal carcinoma; Leucovorin; Oxaliplatin; Phase II study

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTINUOUS INFUSION; DIARRHEA; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; NAUSEA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

EID: 0031774842     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008475122124     Document Type: Article

References (8)

1. Beerblock K, Rinaldi Y, André T et al. Bimonthly high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in advanced colorectal cancer. Cancer 1997; 79: 1100-5.
2. Raymond E, Buquet-Fagot C, Djelloul S et al. Antitumor activity of oxaliplatin in combination with fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers. Anti-Cancer Drugs 1997; 8: 876-85.
3. de Gramont A, Vignoud J, Tournigand C et al. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pre-treated metastatic colorectal cancer. Eur J Cancer 1997; 33: 214-9.
4. Machover D, Diaz-Rubio E, de Gramont A et al. Two consecutive phase II studies of oxaliplatin for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. Ann Oncol 1996; 7: 95-8.
5. Tournigand C, Louvet C, de Gramont A et al. Bimonthly high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion with α-2a-interferon in advanced colorectal cancer. Cancer 1997; 79: 1094-9.
6. Diaz-Rubio E, Sastre J, Zaniboni A et al. Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study. Ann Oncol 1998; 9, 105-8.
7. Berteault-Cvitkovic F, Jami A, Itzakhi M et al. Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer. J Clin Oncol 1996; 14, 2050-8.
8. Andrè T, Bensmaine MA, Louvet C et al. Addition of oxaliplatin (Eloxatine) to the same leucovorin (LV) and 5-fluorouracil (5-EU) bimonthly regimens after progression in patients with metastatic colorectal cancer (MCRC): Proceedings of the Annual Meeting ECCO 9, Eur J Cancer 1997; 33 (Suppl 8): S165 (Abstr 738).